These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7012689)

  • 1. [E-active rosette forming T lymphocytes in the kidney transplant. Significance of serial monitoring].
    Brando B; Civati G; Minetti L
    Minerva Nefrol; 1980; 27(2):279-80. PubMed ID: 7012689
    [No Abstract]   [Full Text] [Related]  

  • 2. [Significance of the rosette formation phenomenon in kidney transplantation].
    Belorusov OS; Polishchuk RV
    Sov Med; 1980; (9):56-60. PubMed ID: 6999635
    [No Abstract]   [Full Text] [Related]  

  • 3. Change of T-lymphocyte ratio after keratoplasty.
    Kelenhegyi C; Süveges I; Alberth B
    Albrecht Von Graefes Arch Klin Exp Ophthalmol; 1979 Jun; 210(4):269-74. PubMed ID: 386821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T-active rosette forming cells as a better index of kidney transplantation recipients' immune reactivity.
    Civati G; Brando B; Broggi ML; Cosci P; Minetti L
    Proc Eur Dial Transplant Assoc; 1980; 17():483-5. PubMed ID: 7017694
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical value of the rosette inhibition test in renal allotransplantation.
    Cantaluppi A; Tarantino A; Donati D; Ponticelli C
    Transplant Proc; 1979 Mar; 11(1):379-81. PubMed ID: 377660
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of different ATG (ATGAM) regimens on levels of rosette-forming cells (RFC), serum horse IgG (HoI), and anti-horse antibodies in kidney transplant patients.
    Satoh P; Elberg A; Davis J; Uittenbogaart C; Fine R; Hardy MA
    Transplant Proc; 1979 Jun; 11(2):1427-8. PubMed ID: 382530
    [No Abstract]   [Full Text] [Related]  

  • 7. The use of circulating rosette-forming cells as a guide to determination of ATG dose (dose-by-rosette).
    Byfield PE; Barth CL; Brodie JA; Cosimi AB; Dienst SG; Elberg AJ; Elfring GL; Hardy MA; Hayashi H; Kountz SL; Lamborn KR; Loughman BE; Sakai A; Satoh PS; Zielinski CM; Wechter WJ
    Transplant Proc; 1978 Sep; 10(3):627-31. PubMed ID: 362648
    [No Abstract]   [Full Text] [Related]  

  • 8. [The value of active T-rosette-forming cells in urine in diagnosis of acute reject reaction].
    Xiao XR
    Zhonghua Wai Ke Za Zhi; 1988 Jun; 26(6):367-9, 384. PubMed ID: 3068020
    [No Abstract]   [Full Text] [Related]  

  • 9. Inhibition of the active E-rosette-forming T lymphocytes by a mesenchyme associated antigen.
    Chevrier A; Delpech B; Halavent C
    Biomedicine; 1980 Feb; 33(1):21-3. PubMed ID: 6966165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Individualized management of immunosuppression according to serial monitoring of immunocompetence.
    Cosimi AB; Delmonico FL; Burdick JF; Russell PS
    Transplant Proc; 1978 Sep; 10(3):647-50. PubMed ID: 362652
    [No Abstract]   [Full Text] [Related]  

  • 11. [Diagnostic value of T- and B- lymphocyte determination in patients with kidney allograft in the early post-transplantation period].
    Voĭlokova RIa; Lobanova ED; Zaretskaia IuM; Rasulova TKh; Rasulova TKh
    Sov Med; 1977 Nov; (11):29-33. PubMed ID: 343264
    [No Abstract]   [Full Text] [Related]  

  • 12. [Standardization of the rosette test for the immunological reactivity of patients after kidney transplant operation (author's transl)].
    Korcáková L; Skibová J
    Cas Lek Cesk; 1981; 120(49):1465-8. PubMed ID: 7034944
    [No Abstract]   [Full Text] [Related]  

  • 13. The in vitro assessment of the immunosuppressive effect of fractionated total lymphoid irradiation in renal allotransplantation.
    Ferguson RM; Sutherland DE; Kim T; Simmons RL; Najarian JS
    Transplant Proc; 1981 Sep; 13(3):1673-5. PubMed ID: 6458136
    [No Abstract]   [Full Text] [Related]  

  • 14. T-RFC monitoring of CMI events in renal allograft recipients.
    Kerman RH; Geis WP
    Transplant Proc; 1978 Sep; 10(3):633-5. PubMed ID: 362649
    [No Abstract]   [Full Text] [Related]  

  • 15. [Selected cellular immunity parameters in patients with Lesniowski-Crohn disease].
    Słotwiński R; Szczygieł B; Lech G; Kolewska D; Wasik M
    Pol Merkur Lekarski; 1997 Nov; 3(17):224-7. PubMed ID: 9523477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Receptor activity of T lymphocytes in patients with atopic dermatitis].
    Dynowska D; Sanokowska E
    Przegl Lek; 1995; 52(6):303-6. PubMed ID: 7568984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Studies on the chromosomes of T lymphocytes in peripheral blood and immunological functions in renal transplant patients].
    Xiao XR
    Zhonghua Wai Ke Za Zhi; 1983 Jan; 21(1):13-6, 61-2. PubMed ID: 6343011
    [No Abstract]   [Full Text] [Related]  

  • 18. Predictive value of active T-RFC in renal allograft survival.
    Kerman RH; Ing TS; Hano JE; Geis WP
    Transplant Proc; 1978 Sep; 10(3):637-8. PubMed ID: 362650
    [No Abstract]   [Full Text] [Related]  

  • 19. Different reconstitution of peripheral blood lymphocytes and dendritic cells in liver and kidney transplant patients.
    Rondelli D; Abbasian J; Arpinati M; Panaro F; Porubsky M; Manzelli A; Oberholzer J; Benedetti E; Testa G
    Transplant Proc; 2005; 37(1):49-50. PubMed ID: 15808543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of active E rosette forming T lymphocytes by hyaluronic acid. Evidence of a receptor for hyaluronic acid on a lymphocyte subpopulation.
    Chevrier A; Girard N; Delpech B; Gilbert D
    Biomed Pharmacother; 1982 Mar; 36(2):100-3. PubMed ID: 6982077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.